We hypothesised that if all HLA-B*15:02 carriers were prevented from CBZ prescription, another common HLA-B75 serotype marker – especially HLA-B*15:21 – would reveal its nature in causing CBZ-SJS. This evidence concerns the gene HLA-B and Schwartz-Jampel syndrome.